The diagnosis of HCC requires evaluation of risk factors (chronic liver disease), tumoral markers (alpha-fetoprotein (AFP) being the most commonly used), and imaging patterns based on the enhancement after intravenous contrast [5]. This evidence concerns the gene AFP and hepatocellular carcinoma.